1. Introduction {#sec1}
===============

Recently, metabolic syndrome has become a serious health problem in advanced countries, and emphasis has been placed on reducing obesity, which is believed to be the main cause of metabolic syndrome. There are numerous reports regarding the antiobesity effects of certain food components. In particular, it was found that green tea and its components, catechins, caffeine, and theanine, have suppressive effects on fat accumulation. Sayama et al. reported that an administration of a diet containing 2% green tea powder suppressed body weight gain and endoceliac fat accumulation and decreased triglycerides (TG) and total cholesterol (TC) in the liver, as well as TG in serum, without reducing food intake in mice \[[@B1]\]. Moreover, to elucidate the inhibitory effects by catechins and caffeine, two major components of green tea, mice were fed diets containing 0.3% catechins and 0.05% caffeine, corresponding to the concentrations found in a 2% green tea powder diet. As a result, it was shown that catechins and caffeine together had similar inhibitory effects of fat accumulation as green tea \[[@B2]\]. Therefore, it was suggested that the combination of catechins and caffeine might be the most effective of all green tea components in suppressing fat accumulation.

It has been reported that catechins, the major component of green tea, have suppressive effects on fat accumulation. Body fat gain in mice fed a high-fat diet was significantly suppressed by catechins, and mRNA expressions of acyl-CoA oxidase (ACO) and medium-chain acyl-CoA dehydrogenase (MCAD), which are related to *β*-oxidation within the liver, were upregulated \[[@B3], [@B4]\]. It was also demonstrated that body weight gain, body fat accumulation, TC and TG levels in the liver, and TG levels in serum were suppressed in rats fed a normal diet and water containing 0.5% catechins \[[@B5]\]. Additionally, a diet containing 1% catechins decreased TG levels and the enzymatic activities of fatty acid synthase (FAS), an enzyme involved in fatty-acid synthesis in rat livers \[[@B6]\].

Furthermore, caffeine, another component of green tea, also possesses antiobesity effects. Rats fed a high-fat diet with 0.05% or 0.1% caffeine demonstrated a reduction in body fat mass, as well as hepatic and serum TC and TG levels. Moreover, serum catecholamine concentrations were increased in rats that were orally administered 5 mg/kg of caffeine \[[@B7]\]. An oral administration of 0.04% caffeine decreased the weight of the parametrial fats pad by 43% in mice \[[@B8]\]. Furthermore, caffeine intake was found to be associated with a reduction in body fat via catecholamine-induced lipolysis and an increase in lipid consumption via thermogenesis within brown adipose tissues \[[@B9]\]. Additionally, it was demonstrated that the thermogenic actions of caffeine were further enhanced by catechins. However, the mechanisms behind the inhibitory effects of fat accumulation by both catechins and caffeine, in particular, their effect on lipid metabolism within liver, are still unclear.

It has been reported that epigallocatechin gallate (EGCG), which makes up about 30% of green tea\'s catechins, also has suppressive effects on fat accumulation. Mice fed a high-fat diet containing EGCG demonstrated a reduction in body fat accumulation and body weight gain \[[@B10]\], an increase in the mRNA expression levels of sterol regulatory element-binding protein-1c (SREBP-1c) and FAS, and a reduction in the mRNA expression levels of carnitine palmitoyltransferase-I (CPT-I) and uncoupling protein 2 (UCP2), all of which are related to *β*-oxidation in the adipose tissue of mice \[[@B11]\]. Moreover, when rats were fed a high-fat diet and water containing green tea or EGCG, the gene expression of SREBP-1c, FAS, malonyl CoA decarboxylase (MCD), and acetyl CoA carboxylase (ACC), which are involved in fatty-acid synthase, as well as peroxisome proliferator-activated receptor *α* (PPAR*α*), CPT-I, and ACO, which are involved in the *β*-oxidation within the liver, were increased by green tea, but not by EGCG \[[@B12]\]. Therefore, it was suggested that EGCG may not affect lipid metabolism in the liver. However, the effects of EGCG and caffeine on lipid metabolism in the liver are yet to be investigated.

The above-mentioned reports demonstrated that catechins, EGCG, and caffeine have suppressive effects on fat accumulation and that the mechanism of the action of catechins may be related to the modification of enzymes involved in lipid metabolism, as well as their transcription factors, within the liver and adipose tissue. We proposed that the combination of catechins and caffeine may have a stronger effect on hepatic lipid metabolism than either alone, since catechins and caffeine appear to be synergistic in their inhibitory effects of fat accumulation.

Thus, to elucidate the mechanism of inhibitory action of fat accumulation by catechins and caffeine, particularly, the effects to hepatic lipid metabolism and to clarify what components of green tea catechins are responsible for the inhibitory effects of fat accumulation by the diet with catechins and caffeine, we investigated the effects of a combination of either catechins or EGCG with caffeine on body and intraperitoneal adipose tissue (IPAT) weights, serum and hepatic lipid levels, as well as the enzymatic activities, and mRNA expression levels of lipid-metabolizing enzymes.

2. Materials and Methods {#sec2}
========================

2.1. Animals and Diets {#sec2.1}
----------------------

Female 10-week-old ICR mice weighing approximately 30--32 g were purchased from an animal breeder (Japan SLC Co., Hamamatsu, Japan) and used in this study. In previous reports, ICR mice were used for the research about inhibitory effects of fat accumulation by green tea and green tea components \[[@B1], [@B2]\]. Weight of intraperitoneal adipose tissue in the control mice was remarkably increased with age, and the increase ratio became about 9% of body weight until 5 months old, even by feeding of commercial diet. Therefore, we also used this mouse strain as a model mouse which characterizes severe fat accumulation *in vivo*. The mice were maintained on standard powdered laboratory chow MF (Oriental Yeast Co. Ltd., Tokyo, Japan).

Catechin powder was purchased from Mitsui Norin Co. (Tokyo, Japan), and EGCG powder was obtained from TEAVIGO, Roche Vitamin Japan Co. (Tokyo, Japan). Caffeine was purchased from WAKO Pure Chemical Industries, Ltd. (Osaka, Japan). Catechin, EGCG, and caffeine powder were mixed into a standard powder diet for mice at concentrations of 0.3%, 0.1%, and 0.05%, respectively, alone and in combination. These concentrations corresponded with those found in a 2% green tea powder diet.

Food intake was measured in a group of 3 mice that were individually housed in mouse cages and fed either a mixed or nonmixed diet and tap water *ad libitum*for 4 weeks. All mice were kept in an air-conditioned (temperature of 24 ± 2°C and humidity of 50 ± 10%) and light-controlled (12 h day: 12 h night; lights on from 08:00 to 20:00) animal room.

Ethical approval for the study was obtained from the Committee for Animal Experimentation of Shizuoka University.

2.2. Sampling Procedures {#sec2.2}
------------------------

After feeding, all mice were fasted for 6 h prior to sacrifice. Following the fasting period, each mouse was deeply anesthetized by an overdose of diethyl ether, and blood was withdrawn from the heart. Serum was isolated from clotted blood by centrifugation at 800 ×g for 15 min at 4°C. Livers and IPAT were weighted. Serum and livers were stored at −80°C until use for the determination of the lipid levels, as well as genetic and enzymatic activities related to lipid metabolism.

2.3. Lipid Analysis {#sec2.3}
-------------------

Serum concentrations of TC and TG were measured enzymatically with test kits (cholesterol C-test and triglyceride G-test, Wako Co., Japan). Lipids within the liver were extracted by using the method described by Folch et al. \[[@B13]\]. TC and TG within the extract were analyzed via the methods described by Zak \[[@B14]\] and Fletcher \[[@B15]\], respectively.

2.4. Sample Preparation for Enzymatic Activity Assay and Western Blotting {#sec2.4}
-------------------------------------------------------------------------

Frozen liver samples were thawed and homogenized at 4°C in a homogenizing solution containing 3 mM Tris-HCl (pH 7.2), 0.25 M sucrose, 1 mM DTT (dithiothreitol), 25 *μ*M ALLN (N-acetyl-leucyl-leucyl-norleucinal), 100 *μ*M AEBSF (4-(2-aminoethyl) benzenesulfonyl-fluoride), 100 *μ*M leupeptin (acetyl-leucyl-leucyl-argininal), and 10 *μ*M E64 (N-(N-(L-3-trans-carboxirane-2-carbonyl)-L-leucyl)-agmatine. The resultant supernatant was used in an assay that determined CPT-II involvement in *β*-oxidation of fatty acid. The rest of the homogenizing solution was centrifuged at 600 ×g for 10 min at 4°C, and some of the supernatant was used for the measurement of ACO activity. The remainder of the supernatant was then centrifuged at 9000 ×g for 10 min at 4°C, and a portion of the supernatant was then used for the measurement of FAS activity. Prior to measuring enzymatic activity, protein concentrations were determined with the Assay Dye Concentrate method. The solutions used for CPT-II and ACO activity measurements were diluted to 10 mg/mL and 15 mg/mL, respectively. The solution used for Western Blotting was diluted to 3 *μ*g/*μ*L.

2.5. Measurement of FAS, ACO, and CPT-II Activity {#sec2.5}
-------------------------------------------------

The enzymatic activity of FAS was measured using a method described by Kelley et al. \[[@B16]\], Nepokroeff et al. \[[@B17]\], and Moriyama et al. \[[@B18]\]. ACO and CPT-II activities were measured, as previously described by Hashimoto et al. \[[@B19]\], Osumi and Hashimoto \[[@B20]\], Markwell et al. \[[@B21]\], and Moriyama et al. \[[@B18]\]. All enzyme activities were measured via a spectrophotometric assay using a recording spectrophotometer (model V630-BIO, JASCO, Tokyo, Japan).

2.6. Western Blot Analysis {#sec2.6}
--------------------------

Total protein was extracted, and 30 ug were loaded in each lane. Protein was separated on a 7.5% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and transferred onto PVDF membranes using a semidry blotter (ATTO, Tokyo, Japan). Membranes were blocked for 1 h in Tris-buffered saline (TBS) containing 2% nonfat dried milk and 0.1% Tween 20, and incubation with primary and secondary antibodies in TBS containing 2% skim milk for 1.5 h and 1 h, respectively. The membranes were then washed in TBS containing 0.1% Tween 20. The primary antibodies used were rabbit antifatty acids synthase polyclonal antibodies, and the secondary antibodies were horseradish peroxidase-conjugated goat anti-rabbit IgG, F(ab′)2 (Santa Cruz Biotech). Lastly, each protein band was detected via chemiluminescence (light capture `II `system, ATTO, Tokyo, Japan). Signal intensities of the PVDF membranes were measured with Image J software (NIH, USA).

2.7. RNA Preparation and Semiquantitative RT-PCR {#sec2.7}
------------------------------------------------

Livers were dissected from each animal and stored at −80°C in RNA*later*solution (Applied Biosystems, NJ, USA) for subsequent RNAs isolation. Total RNAs were isolated with Isogen (Nippongene, Toyama, Japan), according to the manufacturer\'s instructions, followed by deoxyribonuclease digestion. The extracted RNA was analyzed by reverse transcription polymerase chain reaction (RT-PCR) using RNA PCR kits (Applied Biosystems, NJ, USA) according to the supplier\'s instructions, with the exception of RT, which was performed via an oligo-d(T)16. PCR was performed in a 2720 Thermal Cycler (Applied Biosystems) according to the following specifications: (i) 94°C for 45 s to denature the DNA, 60°C for 45 s to allow for primer annealing, and 72°C for 80 s for extension, all of which were performed for 34 cycles (FAS), (ii) 95°C for 1 min to denature the DNA, 62°C for 2 min to allow for primer annealing, and 72°C for 1.5 min for extension, all of which were performed for 32 cycles (ACO), (iii) 94°C for 45 s to denature the DNA, 55°C for 45 s to allow for primer annealing, and 72°C for 30 s for extension, all of which were performed for 26 cycles (CPT-II), (iv) 94°C for 1 min to denature the DNA, 55°C for 1 min to allow for primer annealing, and 72°C for 1 min for extension, all of which were performed for 32 cycles (SREBP-1c), (v) 94°C for 1 min to denature the DNA, 62°C for 2 min to allow for primer annealing, and 72°C for 1.5 min for extension, all of which were performed for 27 cycles (PPAR*α*), and (vi) 94°C for 1 min to denature the DNA, 60°C for 1 min to allow for primer annealing, and 72°C for 1 min for extension, all of which were performed for 25 cycles (*β*-actin). The primer sets used were as follows: 5′-CAC AGT TAA GAG TTC ATA C-3′/5′-TGG TTG CTG TGC ATG GCT C-3′ (426 bp) for FAS \[[@B22]\], 5′-CCA ACA TGA GGA CTA TAA CTT CCT-3/5′-TAC ATA CGT GCC GTC AGG CTT CAC-3′ (661 bp) for ACO \[[@B23]\], 5′-CAC AAC ATC CTG TCC ACC AG-3′/5′-CAT TGC AGC CTA TCC AGT CA-3′ (124 bp) for CPT-II \[[@B24]\], 5′-GGA TGT CAC ACA ATG CAA TTC GCT-3′/5′-TCA CAG AAC GGC TTC CTC AGG TT-3′ (565 bp) for PPAR*α* \[[@B23]\], 5′-GGA GCC ATG GAT TGC ACA TT-3′/5′-AGG AAG GCT TCC AGA GAG GA-3′ (191 bp) for SREBP-1c \[[@B25]\], and 5′-GCC AAC CGT GAA AAG ATG-3′/5′-GAA GGA AGG CTG GAA AAG A-3′ (461 bp) for *β*-actin \[[@B26]\]. The amplified DNA was subjected to electrophoresis on a 1.5% agarose gel and stained with ethidium bromide. The intensity of each PCR product for each gene of interest was measured with Image J software, and the resulting densitometric value was compared to *β*-actin, the internal standard.

2.8. Statistical Analysis {#sec2.8}
-------------------------

A Dunnett\'s multiple comparison test was used for statistical comparisons, and differences were considered significant at *P* \< 0.05.

3. Results {#sec3}
==========

3.1. Body, Liver, and Intraperitoneal Adipose Tissue (IPAT) Weights {#sec3.1}
-------------------------------------------------------------------

The body, liver, and IPAT weights of the control and experimental mice are presented in [Figure 1](#fig1){ref-type="fig"}. There were no significant differences between the control and any of the catechins, EGCG, and caffeine groups in body and liver weights (Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}). IPAT weights were significantly lower in the 0.05% caffeine and 0.3% catechins + 0.05% caffeine groups than the 0.3% catechins and control groups (*P* \< 0.05). The IPAT weights of the 0.05% caffeine and 0.3% catechins + 0.05% caffeine groups were 54.6 and 43.2%, respectively, lower than the control group. Furthermore, IPAT weights were significantly lower in the 0.05% caffeine and 0.1% EGCG + 0.05% caffeine groups than the 0.1% catechins and control groups (*P* \< 0.01). The IPAT weights of the 0.05% caffeine and 0.1% EGCG + 0.05% caffeine groups were 58.2 and 49.1%, respectively, lower than the control group.

3.2. Food Intake {#sec3.2}
----------------

Food intake was compared between the groups which were given catechins, EGCG, and caffeine singly or in combination, and the control group. There were no significant differences between the control group and any of the catechins, EGCG, and caffeine groups ([Table 1](#tab1){ref-type="table"}).

3.3. Lipid Concentrations in Serum and Liver {#sec3.3}
--------------------------------------------

The serum and hepatic TC and TG levels of all groups are shown in [Table 2](#tab2){ref-type="table"}. There were no significant differences in both TC and TG concentrations within the serum and liver among any of the treatment groups and the control group.

3.4. Enzymatic Activities of Fatty-Acid Synthesis and *β*-Oxidation Markers within the Liver {#sec3.4}
--------------------------------------------------------------------------------------------

The enzymatic activities of FAS, ACO, and CPT-II within the liver after treatment with catechins, EGCG, and caffeine are presented in [Figure 2](#fig2){ref-type="fig"}. FAS activity in the 0.3% catechins + 0.05% caffeine group was significantly lower than in the control group (*P* \< 0.05). Conversely, the administration of 0.3% catechins + 0.05% caffeine significantly increased the activities of both ACO and CPT-II (*P* \< 0.05). However, there were no significant effects on the enzymatic activities of FAS, ACO, and CPT-II with either 0.3% catechins or 0.05% caffeine treatment. Furthermore, there were no significant differences in all enzyme activities between the 0.1% EGCG, 0.05% caffeine, 0.1% EGCG + 0.05% caffeine, and control groups.

3.5. FAS Protein Levels in the Liver {#sec3.5}
------------------------------------

Hepatic FAS protein levels in the control and experimental groups are presented in [Figure 3](#fig3){ref-type="fig"}. FAS protein levels in the 0.3% catechins + 0.05% caffeine group tended to be lower than in the control group (*P* = 0.053) ([Figure 3(a)](#fig3){ref-type="fig"}). There were no significant differences in FAS protein levels between the other experimental groups and the control group (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}).

3.6. Gene Expression of FAS, PPAR*α*, ACO, CPT-II, and SREBP-1c in Liver {#sec3.6}
------------------------------------------------------------------------

The expression levels of hepatic FAS, ACO, and CPT-II mRNA of all experimental groups are presented in [Figure 4](#fig4){ref-type="fig"}. The expression of FAS mRNA in the 0.3% catechins + 0.05% caffeine group was significantly lower than in the control group (*P* \< 0.05). However, treatment with either 0.3% catechins or 0.05% caffeine did not have an effect on FAS mRNA levels. The expression of ACO and CPT-II mRNA was not significantly different between all treatment groups and the control group. Moreover, the expression levels of PPAR*α* and SREBP-1c mRNA within the liver was not different in any experimental groups (data not shown).

4. Discussion {#sec4}
=============

In the present study, we focused that the inhibitory effects of fat accumulation by catechins, EGCG, and caffeine and the inhibitory mechanisms through lipid metabolism in the liver. As a result, it was demonstrated that the suppressive effects on fat accumulation by a combination of catechins and caffeine, or EGCG and caffeine, were stronger than a single administration of either catechins, EGCG, or caffeine in mice. Moreover, it was revealed that the inhibitory action of the catechins and caffeine combination appears to be related to an improvement in hepatic lipid metabolism.

Zheng et al. previously reported that mice fed a diet containing 0.3% catechins and 0.05% caffeine in combination for 16 weeks demonstrated a significant suppression in both body weight gain and endoceliac fat accumulation compared to mice fed 0.3% catechins or 0.05% caffeine alone \[[@B2]\]. These findings are corroborated by our observations, where IPAT weights, but not body weights, were significantly reduced by a 4-week diet containing the same concentrations of catechins and caffeine. Therefore, it appears that a combination of catechins and caffeine possesses very strong suppressive effects on fat accumulation, even after a short-term administration period.

It has been previously shown that a 1-month high-fat diet together with 0.5% catechins induces significant reductions in visceral fat weight \[[@B27]\]. Although IPAT weight was not affected by a 0.3% catechins diet alone ([Figure 1](#fig1){ref-type="fig"}), we found that fat accumulation was suppressed by the addition of caffeine. These findings indicate that a lower concentration of catechins is more effective in suppressing fat accumulation in combination with caffeine. Furthermore, there was no suppression of fat accumulation in mice fed diets containing 0.1% EGCG, an amount that is similar to that found in a 0.3% catechins diet. It was previously reported that fat accumulation in mice is suppressed by 5- and 10-fold with diets containing 0.5% and 1% EGCG, respectively \[[@B10], [@B11]\]. However, IPAT weight in mice fed a diet containing a combination of 0.1% EGCG and 0.05% caffeine decreased significantly compared to controls ([Figure 1](#fig1){ref-type="fig"}). These results indicate that even low concentrations of EGCG have stronger suppressing effects on fat accumulation in combination with caffeine. Thus, our results clearly demonstrate that the suppression of fat accumulation by catechins or EGCG is augmented in combination with caffeine, which is also a component of green tea. Additionally, EGCG may be an important factor in the inhibitory effects of fat accumulation by catechins and caffeine. However, the inhibitory effects by EGCG and caffeine were lower in comparison to the combination of catechins and caffeine. Therefore, other catechins, or all catechins including EGCG, may also be involved in suppression of fat accumulation by the combination of catechins and caffeine.

The liver plays an important role in lipid metabolism via various mechanisms, such as fatty-acid synthesis and *β*-oxidation. Murase et al. \[[@B3], [@B4]\] reported that the mRNA expression of ACO and MCAD, both enzymes involved in *β*-oxidation within the peroxisome and mitochondria of cell, were activated in the livers of mice following an administration of a diet containing 0.5% catechins. Accordingly, it was proposed that catechins induce their suppressive effects by upregulating the activities of enzymes involved in the *β*-oxidation of fatty acid and suppression of enzymatic activities involved in fatty acid synthesis within the liver. However, in another study, a 1% catechins diet inhibited FAS activity but did not affect the activities of CPT and ACO \[[@B6]\]. In the present study, we found that hepatic ACO and CPT-II activities were unchanged by 0.3% catechins or caffeine alone. However, a combination of 0.3% catechins and 0.05% caffeine resulted in an upregulation of these enzymes. These results indicate that caffeine possesses synergistic actions with catechins that act to stimulate *β*-oxidation. Interestingly, the gene expression levels of ACO and CPT-II were not different in the livers of mice fed a combination of 0.3% catechins and 0.05% caffeine. Therefore, it appears that the upregulation of enzymatic activities induced by both catechins and caffeine was stimulated by mechanisms other than those involving an upregulation of gene expression.

One potential mechanism for the suppression of fatty acid synthesis in the liver induced by catechins and caffeine may be related to their effects on the mRNA expression of FAS and subsequent protein synthesis. This is based on the fact that only the 0.3% catechins and 0.05% caffeine group demonstrated a downregulation of enzymatic activity and gene expression of FAS, as well as a tendency to have reduced FAS protein levels (Figures [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [4](#fig4){ref-type="fig"}). It was reported that a high dose of EGCG (i.e., 0.5% or more) affects certain enzymes involved in lipid metabolism, including FAS and ACO in the liver \[[@B11], [@B12], [@B28]\]. Even though the diet containing 0.1% EGCG + 0.05% caffeine suppressed fat accumulation in mice, there were no significant differences in the enzymatic activities and mRNA expression of FAS, ACO, and CPT-II (Figures [2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Thus, it appears that EGCG affects lipid metabolism in adipose tissues rather than in the liver, when its concentration is low or when other catechins are not present. Furthermore, EGCG may play an important role in suppressing fat accumulation and improving lipid metabolism within the liver with catechins and caffeine.

It is known that suppression of fatty acid and TG levels is caused by activation of PPAR*α* which is a transcription factor involved in the gene expression of fatty acid oxidation enzymes and suppression of SREBP-1c which is transcription factor related to gene expression of FAS \[[@B29], [@B30]\]. It was reported that there was an increase in the gene expression of PPAR*α*, CPT-1, and ACO, and a reduction in the gene expression of SREBP-1c, FAS, MCD, and ACC in the livers of rats administered 1% green tea for 6 months but not in rats that consumed EGCG alone (i.e., 1 mg/kg/day) \[[@B12]\]. Abe et al. reported that rats administered a green tea beverage containing 540 mg of catechins and 80 mg of caffeine per 350 mL for 4 months demonstrated an increase in PPAR*α* gene expression and an inhibition in glucose-6-phosphatase and FAS gene expression \[[@B31]\]. However, in our results, the mRNA expressions of PPAR*α* and SREBP-1c in liver were not influenced by a diet containing 0.3% catechins + 0.05% caffeine and 0.1% EGCG + 0.05% caffeine. Therefore, it appears that gene expressions of the enzymes involved in fatty acid metabolism were not affected by a low concentration of catechins and caffeine, and EGCG and caffeine.

In conclusion, it was demonstrated that the combination of catechins and caffeine induced its inhibitory effects of fat accumulation by upregulating the activities of enzymes involved in hepatic *β*-oxidation of fatty acid and suppressing the activities of enzymes involved in the fatty acid synthesis, but this was not observed with the EGCG and caffeine combination. Therefore, our results indicate that all catechins, including EGCG or other components, such as epicatechin (EC), epigallocatechin (EGC), and epicatechin gallate (ECG), are involved in suppressing fat accumulation in combination with caffeine.

In this study, we used ICR mouse as a model mouse for severe fat accumulation. Therefore, we did not use a high-fat (calorie) diet. However, our results predicted that a combinational administration of catechins and caffeine or EGCG and caffeine might have antiobesity action. Thus, it was considered that we might be able to examine more elaborate studies of the antiobesity effects by using high-fat diet and other obesity model mice such as C57BL and *ob/ob* mice. Moreover, we focused on the effects of catechins and caffeine on hepatic function, particularly the lipid metabolism. However, adipose tissues were also very important organs on lipid metabolism *in vivo*. Thus, we are already proceeding with research about the effects of catechins, EGCG, and caffeine on lipid metabolism in adipose tissues *in vivo* and adipose cells *in vitro*.

![Effects of catechins, EGCG, and caffeine on weights of body, liver, and intraperitoneal adipose tissues in mice. (a) Weights of body, liver, and intraperitoneal adipose tissues (IPAT) in mice fed the diets containing 0.3% catechins, 0.05% caffeine, 0.3% catechins + 0.05% caffeine for 4 weeks. (b) Weights of body, liver, and IPAT in mice fed the diets containing 0.1% EGCG, 0.05% caffeine, 0.1% EGCG + 0.05% caffeine for 4 weeks. The means and SE for 10 mice are plotted. \*, \*\* Significant difference compared with the control (\**P* \< 0.05, \*\**P* \< 0.01).](JOBES2012-520510.001){#fig1}

![Effects of catechins, EGCG, and caffeine on enzymatic activity related to lipid metabolism in liver in mice. (a) Enzymatic activity of FAS, ACO, and CPT II in liver in mice fed the diets containing 0.3% catechins, 0.05% caffeine, 0.3% catechins + 0.05% caffeine for 4 weeks. (b) Enzymatic activity of FAS, ACO, and CPT II in liver in mice fed the diets containing 0.1% EGCG, 0.05% caffeine, 0.1% EGCG + 0.05% caffeine for 4 weeks. FAS: fatty acid synthase, ACO: acyl-CoA oxidase, CPT II: carnitine palmitoyl transferase II. The means and SE for 10 mice are plotted. \* Significant difference compared with the control (*P* \< 0.05).](JOBES2012-520510.002){#fig2}

![Effects of catechins, EGCG, and caffeine on protein levels of fatty acid synthase in liver in mice. (a1) Fluorescence intensity of fatty acid synthase (FAS) by Western Blotting analysis in liver in mice fed the diets containing 0.3% catechins, 0.05% caffeine, 0.3% catechins + 0.05% caffeine for 4 weeks. Lane 1: control, lane 2: 0.3% catechins, lane 3: 0.05% caffeine, lane 4: 0.3% catechins + 0.05% caffeine. (b1) Fluorescence intensity of FAS by Western Blotting analysis in liver in mice fed the diets containing 0.1% EGCG, 0.05% caffeine, 0.1% EGCG + 0.05% caffeine for 4 weeks. Lane 1: control, lane 2: 0.1% EGCG, lane 3: 0.05% caffeine, lane 4: 0.1% EGCG + 0.05% caffeine. (a2 and b2) The protein levels of FAS determined by Western Blotting analysis in liver in mice fed the diets containing catechins and caffeine (a2) and EGCG and caffeine (b2) for 4 weeks. The level was determined from the fluorescence intensity by a image analysis system and showed as a relative value to the control. Results are given as mean ± SE of 8 mice in each groups.](JOBES2012-520510.003){#fig3}

![Effects of catechins, EGCG, and caffeine on the mRNA expression of FAS, ACO, and CPT II in liver in mice. (a1) Fluorescence intensity of mRNA of FAS, ACO, and CPT II by RT-PCR analysis in liver in mice fed the diets containing 0.3% catechins, 0.05% caffeine, 0.3% catechins + 0.05% caffeine for 4 weeks. Lane 1: control, lane 2: 0.3% catechins, lane 3: 0.05% caffeine, lane 4: 0.3% catechins + 0.05% caffeine. (b1) Fluorescence intensity of mRNA of FAS, ACO, and CPT II by RT-PCR analysis in liver in mice fed the diets containing 0.1% EGCG, 0.05% caffeine, 0.1% EGCG + 0.05% caffeine for 4 weeks. Lane 1: control, lane 2: 0.1% EGCG, lane 3: 0.05% caffeine, lane 4: 0.1% EGCG + 0.05% caffeine. (a2 and b2) Expression levels of mRNA of FAS, ACO, and CPT II determined by RT-PCR analysis in liver in mice fed the diets containing catechins and caffeine (a2) and EGCG and caffeine (b2) for 4 weeks. The level was determined from the fluorescence intensity by a image analysis system and showed as a relative value to the control. Results are given as mean ± SE of 8 mice in each groups. \*Significant difference compared with the control (*P* \< 0.05).](JOBES2012-520510.004){#fig4}

###### 

Effects of catechins, EGCG, and caffeine on food intake in mice.

  --------------- ---------------- ---------------- ---------------------------------
                  \(A\)                             
                                                    
                  Dietary groups                    
  Control         0.3% catechins   0.05% caffeine   0.3% catechins + 0.05% caffeine
  138.15 ± 3.39   134.61 ± 3.71    139.62 ± 2.58    138.68 ± 2.71
                                                    
                  \(B\)                             
                                                    
                  Dietary groups                    
  Control         0.1% EGCG        0.05% caffeine   0.1% EGCG + 0.05% caffeine
  137.93 ± 3.48   129.97 ± 2.40    140.90 ± 3.89    136.82 ± 3.95
  --------------- ---------------- ---------------- ---------------------------------

Values (*g*) are means of total food intake during 4 weeks per mouse ± SE for 3 mice.

###### 

Effects of catechins, EGCG, and caffeine on lipid levels in serum and liver in mice.

  ---------------------------- ---------------- ---------------- ---------------- ---------------------------------
                               \(A\)                                              
                                                                                  
                                                Dietary groups                    
                               Control          0.3% catechins   0.05% caffeine   0.3% catechins + 0.05% caffeine
                                                                                  
  Serum lipids                                                                    
   Triglycerides (mg/mL)       1.39 ± 0.26      1.41 ± 0.23      1.29 ± 0.18      1.14 ± 0.19
   Total cholesterol (mg/mL)   1.39 ± 0.17      1.34 ± 0.08      1.28 ± 0.10      1.34 ± 0.12
  Liver lipids                                                                    
   Triglycerides (mg/g)        78.11 ± 6.21     74.65 ± 7.97     77.98 ± 9.64     73.98 ± 6.57
   Total cholesterol (mg/g)    28.74 ± 1.86     27.15 ± 0.40     30.18 ± 3.21     26.04 ± 1.14
                                                                                  
                               \(B\)                                              
                                                                                  
                                                Dietary groups                    
                               Control          0.1% EGCG        0.05% caffeine   0.1% EGCG + 0.05% caffeine
                                                                                  
  Serum lipids                                                                    
   Triglycerides (mg/mL)       1.56 ± 0.25      1.34 ± 0.11      1.53 ± 0.09      1.50 ± 0.10
   Total cholesterol (mg/mL)   1.21 ± 0.10      1.08 ± 0.07      1.29 ± 0.14      1.15 ± 0.04
  Liver lipids                                                                    
   Triglycerides (mg/g)        103.86 ± 20.21   59.74 ± 11.43    83.70 ± 16.65    80.67 ± 9.90
   Total cholesterol (mg/g)    29.08 ± 1.59     26.06 ± 2.01     26.30 ± 1.91     27.66 ± 0.87
  ---------------------------- ---------------- ---------------- ---------------- ---------------------------------

Values are means ± SE for 10 mice.

[^1]: Academic Editor: Eric Doucet
